Prognosis

EU Regulator Starts Review of Pfizer-BioNTech Covid Vaccine

A health worker injects a person during clinical trials for a Covid-19 vaccine.
Photographer: Eva Marie Uzcategui/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Naomi Kresge

October 6, 2020 at 5:35 AM EDT

Updated on

October 6, 2020 at 6:53 AM EDT

This article is for subscribers only.

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

Europe’s drugs regulator started an early review of an experimental Covid-19 vaccine from Pfizer Inc. and BioNTech SE, potentially speeding the shot’s assessment and reducing its time to market.